{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:32:22Z","timestamp":1790947942845,"version":"4.1.0"},"reference-count":91,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Women with cardiovascular disease are underdiagnos-ed, undertreated and under-represented in research. Even though the increased risk of cardiovascular disease among patients with psoriasis is well establi-shed, only a few studies have examined women with psoriasis. This study examined the prevalence of cardio-vascular risk factors and cardiovascular disease among women with psoriasis. Using the Copenhagen City Heart Study and the Copenhagen General Population Study, 66,420 women were included in a cross-sectional design. Of these, 374 (0.56%) women had hospital-diagnosed psoriasis. Women with vs with-out hospital-diagnosed psoriasis had higher odds ratios of having traditional cardiovascular risk factors, including hypertriglyceridaemia, smoking, obesity, type 2 diabetes, and low physical activity, and of having non-traditional cardiovascular risk factors, including low level of education, high level of psycho-social stress, and low-grade inflammation. Compared with women from the general population, the multi-variable adjusted odds ratio of heart failure and ischaemic cerebrovascular disease in women with hospital-diagnosed psoriasis was 2.51 (95% confidence interval 1.33\u20134.73) and 2.06 (1.27\u20133.35). In conclusion, women with hospital-diagnosed psoriasis have a higher prevalence of traditional and non- traditional cardiovascular risk factors, and increased risk of heart failure and ischaemic cerebrovascular disease, even after adjusting for these cardiovascular risk factors.<\/jats:p>","DOI":"10.2340\/actadv.v102.2244","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T12:47:19Z","timestamp":1663591639000},"page":"adv00789","source":"Crossref","is-referenced-by-count":6,"title":["Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis"],"prefix":"10.2340","volume":"102","author":[{"given":"Charlotte","family":"N\u00e4slund-Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-1110","authenticated-orcid":false,"given":"Signe","family":"Vedel-Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-4133","authenticated-orcid":false,"given":"Stig Egil","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9680","authenticated-orcid":false,"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"22171","unstructured":"Get the facts about psoriasis and psoriatic arthritis:: National Psoriasis Foundation. [Accessed on July 6, 2021] Available from: https:\/\/www.psoriasis.org\/psoriasis-statistics\/"},{"key":"22172","doi-asserted-by":"crossref","unstructured":"Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013; 149: 1173-1179.","DOI":"10.1001\/jamadermatol.2013.5015"},{"key":"22173","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2013.5015","DOI":"10.1001\/jamadermatol.2013.5015"},{"key":"22174","doi-asserted-by":"crossref","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 2017; 76: 377-390.","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"22175","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2016.07.064","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"22176","doi-asserted-by":"crossref","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735-1741.","DOI":"10.1001\/jama.296.14.1735"},{"key":"22177","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.296.14.1735","DOI":"10.1001\/jama.296.14.1735"},{"key":"22178","doi-asserted-by":"crossref","unstructured":"Ahlehoff O, Gislason GH, Charlot M, J\u00f8rgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.","DOI":"10.1111\/j.1365-2796.2010.02310.x"},{"key":"22179","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02310.x","DOI":"10.1111\/j.1365-2796.2010.02310.x"},{"key":"22180","doi-asserted-by":"crossref","unstructured":"Miller IM, Ellervik C, Yazdanyar S, Jemec GBE. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013; 69: 1014-1024.","DOI":"10.1016\/j.jaad.2013.06.053"},{"key":"22181","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.053","DOI":"10.1016\/j.jaad.2013.06.053"},{"key":"22182","doi-asserted-by":"crossref","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010; 163: 586-592.","DOI":"10.1111\/j.1365-2133.2010.09941.x"},{"key":"22183","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09941.x","DOI":"10.1111\/j.1365-2133.2010.09941.x"},{"key":"22184","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149: 84-91.","DOI":"10.1001\/2013.jamadermatol.406"},{"key":"22185","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/2013.jamadermatol.406","DOI":"10.1001\/2013.jamadermatol.406"},{"key":"22186","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014; 19: 304-314.","DOI":"10.1111\/bjd.12670"},{"key":"22187","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.12670","DOI":"10.1111\/bjd.12670"},{"key":"22188","doi-asserted-by":"crossref","unstructured":"Lai YC, Yew YW. Psoriasis as an independent risk factor for cardiovascular disease: an epidemiologic analysis using a national database. J Cutan Med Surg 2016; 20: 327-333.","DOI":"10.1177\/1203475415602842"},{"key":"22189","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1203475415602842","DOI":"10.1177\/1203475415602842"},{"key":"22190","doi-asserted-by":"crossref","unstructured":"Boehncke W-H, Boehncke S, Tobin A-M, Kirby B. The \"psoriatic march\": a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-307.","DOI":"10.1111\/j.1600-0625.2011.01261.x"},{"key":"22191","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x","DOI":"10.1111\/j.1600-0625.2011.01261.x"},{"key":"22192","doi-asserted-by":"crossref","unstructured":"Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.","DOI":"10.1038\/ni.2001"},{"key":"22193","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ni.2001","DOI":"10.1038\/ni.2001"},{"key":"22194","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Voyles S V., Armstrong EJ, Fuller EN, Rutledge JC. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 2011; 20: 544-549.","DOI":"10.1111\/j.1600-0625.2011.01308.x"},{"key":"22195","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01308.x","DOI":"10.1111\/j.1600-0625.2011.01308.x"},{"key":"22196","doi-asserted-by":"crossref","unstructured":"Li WQ, Han JL, Manson JE, Rimm EB, Rexrode KM, Curhan GC, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol 2012; 166: 811-818.","DOI":"10.1111\/j.1365-2133.2011.10774.x"},{"key":"22197","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10774.x","DOI":"10.1111\/j.1365-2133.2011.10774.x"},{"key":"22198","doi-asserted-by":"crossref","unstructured":"Garshick MS, Vaidean G, Nikain CA, Chen Y, Smilowitz NR, Berger JS. Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis. Int J Womens Dermatol 2019; 5: 251-255.","DOI":"10.1016\/j.ijwd.2019.05.003"},{"key":"22199","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.05.003","DOI":"10.1016\/j.ijwd.2019.05.003"},{"key":"22200","doi-asserted-by":"crossref","unstructured":"Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women. Circulation 2016; 133: 916-947.","DOI":"10.1161\/CIR.0000000000000351"},{"key":"22201","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1161\/CIR.0000000000000351","DOI":"10.1161\/CIR.0000000000000351"},{"key":"22202","doi-asserted-by":"crossref","unstructured":"Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet 2021; 397: 2385-2438.","DOI":"10.1016\/S0140-6736(21)00684-X"},{"key":"22203","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(21)00684-X","DOI":"10.1016\/S0140-6736(21)00684-X"},{"key":"22204","doi-asserted-by":"crossref","unstructured":"Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.","DOI":"10.1159\/000249365"},{"key":"22205","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000249365","DOI":"10.1159\/000249365"},{"key":"22206","doi-asserted-by":"crossref","unstructured":"Danielsen K, Wilsgaard T, Olsen AO, Eggen AE, Olsen K, Cassano PA, et al. Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol 2015; 172: 419-427.","DOI":"10.1111\/bjd.13288"},{"key":"22207","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.13288","DOI":"10.1111\/bjd.13288"},{"key":"22208","doi-asserted-by":"crossref","unstructured":"Sondermann W, Djeudeu Deudjui DA, K\u00f6rber A, Slomiany U, Brinker TJ, Erbel R, et al. Psoriasis, cardiovascular risk factors and metabolic disorders: sex-specific findings of a population-based study. J Eur Acad Dermatol Venereol 2020; 34: 779-786.","DOI":"10.1111\/jdv.16029"},{"key":"22209","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.16029","DOI":"10.1111\/jdv.16029"},{"key":"22210","doi-asserted-by":"crossref","unstructured":"Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J 2017; 38: 2478-2486.","DOI":"10.1093\/eurheartj\/ehx163"},{"key":"22211","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx163","DOI":"10.1093\/eurheartj\/ehx163"},{"key":"22212","doi-asserted-by":"crossref","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29: 541-549.","DOI":"10.1007\/s10654-014-9930-3"},{"key":"22213","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s10654-014-9930-3","DOI":"10.1007\/s10654-014-9930-3"},{"key":"22214","doi-asserted-by":"crossref","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449-490.","DOI":"10.2147\/CLEP.S91125"},{"key":"22215","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/CLEP.S91125","DOI":"10.2147\/CLEP.S91125"},{"key":"22216","doi-asserted-by":"crossref","unstructured":"Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis 2017; 76: 1591-1597.","DOI":"10.1136\/annrheumdis-2016-210963"},{"key":"22217","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-210963","DOI":"10.1136\/annrheumdis-2016-210963"},{"key":"22218","doi-asserted-by":"crossref","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014; 384: 626-635.","DOI":"10.1016\/S0140-6736(14)61177-6"},{"key":"22219","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(14)61177-6","DOI":"10.1016\/S0140-6736(14)61177-6"},{"key":"22220","doi-asserted-by":"crossref","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377: 1119-1131.","DOI":"10.1056\/NEJMoa1707914"},{"key":"22221","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1707914","DOI":"10.1056\/NEJMoa1707914"},{"key":"22222","doi-asserted-by":"crossref","unstructured":"Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-796.","DOI":"10.1111\/j.1468-3083.2009.03527.x"},{"key":"22223","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03527.x","DOI":"10.1111\/j.1468-3083.2009.03527.x"},{"key":"22224","doi-asserted-by":"crossref","unstructured":"Vachatova S, Andrys C, Krejsek J, Salavec M, Ettler K, Rehacek V, et al. Metabolic syndrome and selective inflammatory markers in psoriatic patients. J Immunol Res 2016; 2016: 1-8.","DOI":"10.1155\/2016\/5380792"},{"key":"22225","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1155\/2016\/5380792","DOI":"10.1155\/2016\/5380792"},{"key":"22226","doi-asserted-by":"crossref","unstructured":"Ucak S, Ekmekci TR, Basat O, Koslu A, Altuntas Y. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 517-522.","DOI":"10.1111\/j.1468-3083.2006.01499.x"},{"key":"22227","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01499.x","DOI":"10.1111\/j.1468-3083.2006.01499.x"},{"key":"22228","doi-asserted-by":"crossref","unstructured":"Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007; 157: 1249-1251.","DOI":"10.1111\/j.1365-2133.2007.08190.x"},{"key":"22229","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08190.x","DOI":"10.1111\/j.1365-2133.2007.08190.x"},{"key":"22230","doi-asserted-by":"crossref","unstructured":"Gyldenl\u00f8ve M, Storgaard H, Holst JJ, Vilsb\u00f8ll T, Knop FK, Skov L. Patients with psoriasis are insulin resistant. J Am Acad Dermatol 2015; 72: 599-605.","DOI":"10.1016\/j.jaad.2015.01.004"},{"key":"22231","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2015.01.004","DOI":"10.1016\/j.jaad.2015.01.004"},{"key":"22232","doi-asserted-by":"crossref","unstructured":"Gisondi P, Fantin F, Del Giglio M, Valbusa F, Marino F, Zamboni M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-113.","DOI":"10.1159\/000182256"},{"key":"22233","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000182256","DOI":"10.1159\/000182256"},{"key":"22234","doi-asserted-by":"crossref","unstructured":"Karadag AS, Yavuz B, Ertugrul DT, Akin KO, Yalcin AA, Deveci OS, et al. Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int J Dermatol 2010; 49: 642-646.","DOI":"10.1111\/j.1365-4632.2009.04358.x"},{"key":"22235","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04358.x","DOI":"10.1111\/j.1365-4632.2009.04358.x"},{"key":"22236","doi-asserted-by":"crossref","unstructured":"Garshick MS, Barrett TJ, Wechter T, Azarchi S, Scher JU, Neimann A, et al. Inflammasome signaling and impaired vascular health in psoriasis. Arterioscler Thromb Vasc Biol 2019; 39: 787-798.","DOI":"10.1161\/ATVBAHA.118.312246"},{"key":"22237","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1161\/ATVBAHA.118.312246","DOI":"10.1161\/ATVBAHA.118.312246"},{"key":"22238","doi-asserted-by":"crossref","unstructured":"Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses' health study II. Arch Intern Med 2007; 167: 1670-1675.","DOI":"10.1001\/archinte.167.15.1670"},{"key":"22239","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archinte.167.15.1670","DOI":"10.1001\/archinte.167.15.1670"},{"key":"22240","doi-asserted-by":"crossref","unstructured":"La Sala L, Pontiroli AE. Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci 2020; 21: 8178.","DOI":"10.3390\/ijms21218178"},{"key":"22241","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/ijms21218178","DOI":"10.3390\/ijms21218178"},{"key":"22242","doi-asserted-by":"crossref","unstructured":"Kolb H, Martin S. Environmental\/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med 2017; 15: 131.","DOI":"10.1186\/s12916-017-0901-x"},{"key":"22243","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12916-017-0901-x","DOI":"10.1186\/s12916-017-0901-x"},{"key":"22244","doi-asserted-by":"crossref","unstructured":"Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of us female nurses. Arch Dermatol 2009; 145: 379-382.","DOI":"10.1001\/archdermatol.2009.48"},{"key":"22245","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archdermatol.2009.48","DOI":"10.1001\/archdermatol.2009.48"},{"key":"22246","doi-asserted-by":"crossref","unstructured":"Frankel HC, Han J, Li T, Qureshi AA. The association between physical activity and the risk of incident psoriasis. Arch Dermatol 2012; 148: 918-924.","DOI":"10.1001\/archdermatol.2012.943"},{"key":"22247","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archdermatol.2012.943","DOI":"10.1001\/archdermatol.2012.943"},{"key":"22248","doi-asserted-by":"crossref","unstructured":"Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, et al. Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries. PLoS One 2012; 7:e36342.","DOI":"10.1371\/journal.pone.0036342"},{"key":"22249","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0036342","DOI":"10.1371\/journal.pone.0036342"},{"key":"22250","doi-asserted-by":"crossref","unstructured":"Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 67: 76-85.","DOI":"10.1016\/j.jaad.2011.06.035"},{"key":"22251","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2011.06.035","DOI":"10.1016\/j.jaad.2011.06.035"},{"key":"22252","doi-asserted-by":"crossref","unstructured":"Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, et al. Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 2014; 16: 743-748.","DOI":"10.1002\/ejhf.113"},{"key":"22253","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ejhf.113","DOI":"10.1002\/ejhf.113"},{"key":"22254","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev 2017; 97: 1-37.","DOI":"10.1152\/physrev.00021.2015"},{"key":"22255","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1152\/physrev.00021.2015","DOI":"10.1152\/physrev.00021.2015"},{"key":"22256","doi-asserted-by":"crossref","unstructured":"Bergami M, Scarpone M, Bugiardini R, Cenko E, Manfrini O. Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease. Rev Cardiovasc Med 2022; 23: 19.","DOI":"10.31083\/j.rcm2301019"},{"key":"22257","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.31083\/j.rcm2301019","DOI":"10.31083\/j.rcm2301019"},{"key":"22258","doi-asserted-by":"crossref","unstructured":"Tur E, Maibach HI. Gender and dermatology. Springer; 2018: p. 63-73.","DOI":"10.1007\/978-3-319-72156-9"},{"key":"22259","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/978-3-319-72156-9","DOI":"10.1007\/978-3-319-72156-9"},{"key":"22260","doi-asserted-by":"crossref","unstructured":"Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, et al. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 2015; 135: 2189-2197.","DOI":"10.1038\/jid.2015.87"},{"key":"22261","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/jid.2015.87","DOI":"10.1038\/jid.2015.87"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2244\/7394","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2244\/7395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2244\/7394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T08:38:25Z","timestamp":1665477505000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/2244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":91,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.2244","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,11]]}}}